A Randomized, Double-Blind, Placebo Controlled Study to Assess Safety and Tolerability of RotaVac Vaccine (Live Attenuated Bovine-Human (UK) Reassortant Pentavalent Rotavirus Vaccine).

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Study to Assess Safety and Tolerability of RotaVac Vaccine (Live Attenuated Bovine-Human (UK) Reassortant Pentavalent Rotavirus Vaccine).

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Bovine rotavirus vaccine reassortant (Primary)
  • Indications Rotavirus infections
  • Focus Adverse reactions
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 13 Jul 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 05 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top